Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BA.5.2.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
ED.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BF.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BA.2.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XATENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.384ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.20.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.619.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.12.1 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.260ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.456ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.16 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.428ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.374ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used